184 related articles for article (PubMed ID: 11041370)
1. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan.
Tomita Y; Miyamura Y; Kono M; Nakamura R; Matsunaga J
Pigment Cell Res; 2000; 13 Suppl 8():130-4. PubMed ID: 11041370
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of congenital hypopigmentary disorders in humans: a review.
Boissy RE; Nordlund JJ
Pigment Cell Res; 1997; 10(1-2):12-24. PubMed ID: 9170158
[TBL] [Abstract][Full Text] [Related]
3. [Hereditary hypomelanocytoses: the role of PAX3, SOX10, MITF, SNAI2, KIT, EDN3 and EDNRB genes].
Otręba M; Miliński M; Buszman E; Wrześniok D; Beberok A
Postepy Hig Med Dosw (Online); 2013 Nov; 67():1109-18. PubMed ID: 24379252
[TBL] [Abstract][Full Text] [Related]
4. Partial Oculocutaneous Albinism: Two Siblings with Features of both Hermansky Pudlak and Waardenburg's Syndrome.
Ishaq M; Niazi MK; Khan MS; Nadeem Y
J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S43-4. PubMed ID: 25933462
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.
Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL
J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222
[TBL] [Abstract][Full Text] [Related]
6. The molecular genetics of albinism and piebaldism.
Tomita Y
Arch Dermatol; 1994 Mar; 130(3):355-8. PubMed ID: 8129415
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of coat colour-associated mutations in humans, mice and other mammals.
Reissmann M; Ludwig A
Semin Cell Dev Biol; 2013; 24(6-7):576-86. PubMed ID: 23583561
[TBL] [Abstract][Full Text] [Related]
8. [Hypomelanoses transmitted from generation to generation].
Otręba M; Buszman E; Miliński M; Wrześniok D
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1081-90. PubMed ID: 25228517
[TBL] [Abstract][Full Text] [Related]
9. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
[TBL] [Abstract][Full Text] [Related]
10. Current landscape of Oculocutaneous Albinism in Japan.
Okamura K; Suzuki T
Pigment Cell Melanoma Res; 2021 Mar; 34(2):190-203. PubMed ID: 32969595
[TBL] [Abstract][Full Text] [Related]
11. Oculocutaneous albinism and analysis of tyrosinase gene in Japanese patients.
Tomita Y; Miyamura Y
Nagoya J Med Sci; 1998 Oct; 61(3-4):97-102. PubMed ID: 9879192
[TBL] [Abstract][Full Text] [Related]
12. Genetics of pigmentary disorders.
Tomita Y; Suzuki T
Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):75-81. PubMed ID: 15452859
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism.
Wei AH; Zang DJ; Zhang Z; Liu XZ; He X; Yang L; Wang Y; Zhou ZY; Zhang MR; Dai LL; Yang XM; Li W
J Invest Dermatol; 2013 Jul; 133(7):1834-40. PubMed ID: 23364476
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.
Wei A; Wang Y; Long Y; Wang Y; Guo X; Zhou Z; Zhu W; Liu J; Bian X; Lian S; Li W
J Invest Dermatol; 2010 Mar; 130(3):716-24. PubMed ID: 19865097
[TBL] [Abstract][Full Text] [Related]
15. [Genetics of oculocutaneous albinism].
Zühlke C; Stell A; Käsmann-Kellner B
Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
[TBL] [Abstract][Full Text] [Related]
16. P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome.
Garrison NA; Yi Z; Cohen-Barak O; Huizing M; Hartnell LM; Gahl WA; Brilliant MH
J Med Genet; 2004 Jun; 41(6):e86. PubMed ID: 15173252
[No Abstract] [Full Text] [Related]
17. Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising.
Power B; Ferreira CR; Chen D; Zein WM; O'Brien KJ; Introne WJ; Stephen J; Gahl WA; Huizing M; Malicdan MCV; Adams DR; Gochuico BR
Orphanet J Rare Dis; 2019 Feb; 14(1):52. PubMed ID: 30791930
[TBL] [Abstract][Full Text] [Related]
18. [Oculocutaneous albinism].
Lacour JP; Ortonne JP
Ann Pediatr (Paris); 1992 Sep; 39(7):409-18. PubMed ID: 1416662
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
Ullah MI
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
[TBL] [Abstract][Full Text] [Related]
20. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
